12
Supplementary Fig. 1. (a) Vector map of pCX-EGFP vector construct. (b) Vector map of Amh-Ires2-Egfp vector construct. (c) Vector Map of Bucsn2-Ires2-Egfp Vector Construct. (d) Vector map of Fetuin-A shRNA vector construct.

(a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Fig. 1.

(a) Vector map of pCX-EGFP vector construct.

(b) Vector map of Amh-Ires2-Egfp vector construct.

(c) Vector Map of Bucsn2-Ires2-Egfp Vector Construct.

(d) Vector map of Fetuin-A –shRNA vector construct.

Page 2: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Table 1 : Primer sequence used for genotyping of transgenic lines

Si. No.

Constructs Primer 5’ 3’ T anneal

(0C)Product

Size (bp)

1 pCX-Egfp F: CGACAACCACTACCTGAGCAR: AGCCAGAAGTCAGATGCTCAA

60 300

2 Amh-IRES2-Egfp F: AAGCCCTTTGAGACAGTCGCR: ATATAGACAAACGCACACCG

62 295

3 Fetuin-A shRNA F: GACGGTACAGGCCAGACAATR: TTCTCTGTCCCACTCCATCC

61 292

4 Bucsn2-IRES2-Egfp F: GAAACAATCTAGTCAATCCAAGR: ATATAGACAAACGCACACCG

62 900

Page 3: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Table 2:

DNA concentration and conditions used while standardizing in vivo Testicular

transfection using linearized pCX-EGFP plasmid suspended in Tris-HCl solution.

Abbreviation used. DOI: date of injection, Conc.: Concentration, Vol.: Volume, amt.:

Amount, Highlighted row depicts the most suitable condition of in vivo testis

transfection Used in this study. + denotes minimum and ++++ denotes maximum

fluorescence.

Page 4: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Fig. 2.

PCR genotyping of the offspring obtained from fore founder AU 4 & AU 5

transfected with pCX-Egfp. AU 4 & AU 5 were mated with wild type (Wt) female

mice. Pups of the G2 generation were generated by mating males and females of

slot blot positive animals (C11 & C16) from G1 generation. ‘C #’ denotes

transgenic animal of pCX-Egfp line from FVB/J strain. Wt denotes wild type mice.

NT denotes no template. +ve denotes plasmid DNA.

Page 5: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Fig. 3.

Slot blot analysis of the PCR positive progeny obtained from the fore founder

males AU 4, AU 5 and founder animals C 11 and C 16. C 3 – C 18 (G1

generation pups of AU 4 & AU 5); C 19 – C 32 (G2 generation pups of C 11 & C

16); Wt1-Wt4 gDNA from four different wild type mice. pCX-Egfp fragment was

used as positive control. The gDNA were hybridized with GFP probe isolated

from pCX-Egfp plasmid by restriction digestion. ‘C #’ denotes transgenic animal

of pCX-Egfp line. Wt - denotes wild type mice. +ve denotes plasmid DNA

fragment.

Page 6: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

a

Supplementary Fig. 4.

(a) PCR genotyping of the offspring using genomic DNA (gDNA) obtained

from fore founder MG 1 & MG 2 transfected with Amh-IRES2-Egfp. MG 1 &

MG 2 were mated with wild type female mice. MG denotes the forefounder

animal of Amh-IRES2-Egfp. MT denotes transgenic animal of Amh-IRES2-

Egfp line. Wt denotes wild type mice. NT denotes no template. +ve denotes

plasmid DNA.

Page 7: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Fig. 4.

(b) Slot blot analysis of the PCR positive progenies obtained from the fore founder

males MG 1, MG 2 and founder animals MT 5 and MT 21. MT 3- MT 33 (G1

generation pups of MG 1 & MG 2); MT 42- MT 60 (G2 generation pups of MT 5 &

MT 21); Wt1-Wt4 gDNA from four different wild type mice. Ires2-Egfp fragment was

used as positive control. The gDNA were probed with Ires2-Egfp fragment isolated

from Amh-Ires2-Egfp plasmid by restriction digestion. MT - denotes transgenic animal

of Amh-Ires2-Egfp line from FVB/J strain. Wt– denotes wild type mice.

(c) Shows restriction pattern and probe binding region for southern blot analysis.

b

BamHI

1.3kb 4kb

Total length of delivered transgene (~5.3kb)

c

Probe

Page 8: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

b

a

Supplementary Fig. 5.

(a) Absence of EGFP expression in Liver (i & ii) ; Spleen (iii & iv) ; and skin (v &

vi) of 5 days old Amh-Ires2-Egfp transgenic mouse. Scale bar: i - iv 20 µm; v & vi

50 µm.

(b) EGFP expression in testicular section of adult (42 days old) Amh-Ires2-Egfp

transgenic mouse. Note: non-specific staining in interstitial area. Scale bar: 50 µm.

Page 9: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Fig. 6.

PCR genotyping of the offspring using gDNA obtained from post weaning tail

biopsies of progeny generated from fore founder TBa and TBc transfected with

Bucsn2-Ires2-Egfp. Fore founder TBa and TBc were mated with wild type

female mice. Pups of the G2 generation were generated by mating males and

females of PCR positive animals from G1 generation (TBc 1 & TBc 7).

Lanes 1-7: TBa 1 - TBa 7. Lanes 8-17: TBc 1 – TBc 10. Lanes 22-30: TBc 18-

TBc 26. Lanes 18-19 and 32 & 34 : gDNA of Wt mice as negative control.

Lanes 20 & 36: no template. Lanes 21 and 38: Bucsn2-Ires2-Egfp plasmid

DNA as positive control

22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38

TBc7TBc1

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

WtTBa

G1

G2

WtTBa

Page 10: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

EGFP 28Kda

β-actin 42 kda

b

Supplementary Fig. 7.

(a) Slot blot analysis of the PCR positive progenies obtained from the fore

founder males TBa, TBc and founder animals TBc 1 & TBc 7. TBa 1- TBa 7

(G1 generation pups of TBa); TBc 1 – TBc 10 (G1 generation pups of TBc);

TBc 18 – TBc 26 (G2 generation pups of TBc 1 & TBc 7); WT1-WT4 gDNA

from four different wild type mice. Bucsn2-Ires2-Egfp fragment was used as

positive control. The gDNA were probed with Ires2-Egfp fragment isolated from

Bucsn2-Ires2-Egfp plasmid by restriction digestion. TBa (#) and TBc (#) -

denotes transgenic animal of Bucsn2-Ires2-Egfp line from FVB/J strain. TBa &

TBc - denotes fore-founder animals of Bucsn2-Ires2-Egfp. Wt - denotes wild

type mice.

(b) Protein from mammary glands of three different transgenic females and two

different wild type mice was probed with GFP antibody. GFP expression (~28

kDa) was observed in transgenic mice whereas there is no GFP signal in wild

type mice. β-actin expression was observed in all the samples probed.

aTBa 1

TBa 2

TBa 3

TBa 4

TBa 5

TBa 6

TBa 7

TBc 1

TBc 2

TBc 3

TBc 4

TBc 5

TBc 6

TBc 7

TBc 8

TBc 9

TBc 10

TBc 18

TBc 19

TBc 20

TBc 21

TBc 22

TBc 23

TBc 24

TBc 25

TBc 26

Wt 1

Wt 2

Wt 3

Wt 4

+Ve

+Ve

Page 11: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Fig. 8.

Slot blot analysis of the progeny obtained from the fore founder males 1FT,

2FT, and 3FT. 1FT1-1FT7 (G1 generation pups of 1FT); 2FT1-2FT17 (G1

generation pups of 2FT); 3FT1-3FT12 (G1 generation pups of 3FT); Wt1-Wt4

gDNA from four different wild type mice. FT - denotes Fetuin- A shRNA

expressing transgenic mice. Wt – denotes wild type mice.

Page 12: (a) Vector map of vector construct. · Table showing comparison of occurance of transgene positive pups in percentile, when different constructs were used as transgene. Transgene

Supplementary Table 3:

Table showing the inheritance of transgene in G1 and G2 progeny of fore

founder mice generated by present procedure.

Supplementary Table 4:

Table showing comparison of occurance of transgene positive pups in

percentile, when different constructs were used as transgene.

Transgene Tg Positive Pups/Total Pups Born (in G1)

Instance of TgPositive Pups

pCX-EGFP 13/24 54.16 %

Amh-IRES2-Egfp 21/40 52.5 %

Bucn2-IRES2-Egfp 12/18 66.66 %

Fetuin-A-ShRNA 16/36 44.44 %

Average of all percentile

54.44 %